CRYPTO:INJUSD

Injective Usd Stock News

etoro logo Buy INJUSD
*Your capital is at risk
$6.40
-0.110 (-1.69%)
At Close: Jun 03, 2026
Injective (INJ) shows bullish momentum at $3.41 with neutral RSI and key resistance breaks. Analysts target $3.50-$4.00 range within 4-6 weeks as technical indicators align.
TL;DR INJ jumped over 12% after IIP-619 passed, trading near $3.387 and printing an intraday spike to $3.95, despite broad weakness. The proposal won 99.99% support from staked participants and target
Injective (INJ), a Layer 1 blockchain project designed for DeFi applications, has recently delivered notable price action. The token surged more than 12% while most altcoins remained deep in the red.
Injective (INJ) trades at $3.17 with neutral RSI at 36.10. Technical analysis suggests potential bounce to $3.35 resistance or fall to $2.98 support level.
Altcoin markets remain highly reactive as February enters its third week, with several major tokens approaching critical technical inflection points. While broader sentiment remains fragile, select as
INJ Price Prediction Summary • Short-term target (1 week): $3.41 • Medium-term forecast (1 month): $3.41-$3.90 range • Bullish breakout level: $3.41 • Critical support: $3.
Injective (INJ) shows mixed signals at $3.20 with neutral RSI and bearish momentum. Technical analysis suggests potential recovery to $3.50-$4.00 range within 4-6 weeks if key resistance breaks.
INJ drops from $4B to $300M as TVL remains low and price structure fails to hold key levels
INJ trades at $3.01 with RSI at 28.31 showing oversold conditions. Technical analysis suggests potential bounce to $3.
Injective (INJ) trades at $3.00 with oversold RSI at 28.00, targeting $4.50 recovery by March as technical indicators suggest potential bounce from current levels.
Injective (INJ) trades at $3.06 with RSI at 28.83 showing oversold conditions. Technical analysis suggests potential bounce toward $4.
Injective (INJ) shows oversold conditions at $3.33 with RSI at 26.78, targeting $4.50 recovery by March 2026 as technical indicators suggest potential bounce from current support levels.
Injective (INJ) trading at $3.65 shows potential 65-76% upside to analyst targets of $5.80-$6.20 by February, despite current bearish momentum and oversold conditions.
Injective (INJ) trades at $3.66 with mixed signals. Technical analysis suggests potential recovery to $4.20-$4.70 range by March 2026, though bearish momentum persists.
INJ trades at $3.72 with bearish momentum but shows oversold signals. Technical analysis suggests potential recovery to $4.20-$4.50 range within 4-6 weeks if key support holds.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE